Regeneron Pharmaceuticals Inc. buy BMO Capital Markets
Start price
01.11.24
/
50%
€779.00
Target price
01.11.25
€1,096.8
Performance (%)
-27.09%
End price
02.11.25
€568.00
Summary
This prediction ended on 02.11.25 with a price of €568.00. The prediction for Regeneron Pharmaceuticals Inc. disappointed with a performance of -27.09%. BMO_Capital_Markets has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Dividends of €2.60 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 3.832% | 3.832% | -2.643% |
| iShares Core DAX® | 0.299% | 4.557% | 21.480% |
| iShares Nasdaq 100 | 0.666% | 2.752% | 6.184% |
| iShares Nikkei 225® | -0.656% | 0.000% | 13.889% |
| iShares S&P 500 | 0.352% | 1.854% | 3.566% |
Comments by BMO_Capital_Markets for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target lowered by analysts at BMO Capital Markets from $1,300.00 to $1,190.00. They now have an "outperform" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€681.40
04.02.25
04.02.25
€869.77
04.02.26
04.02.26
-3.92%
08:41
08:41
Stopped prediction by BMO_Capital_Markets for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€625.20
04.12.25
04.12.25
€728.79
04.12.26
04.12.26
4.16%
08:41
08:41
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€494.10
04.08.25
04.08.25
€552.90
04.08.26
04.08.26
32.15%
08:41
08:41
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€427.60
02.06.25
02.06.25
€527.70
02.06.26
02.06.26
52.70%
08:41
08:41
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€515.60
30.04.25
30.04.25
€703.60
30.04.26
30.04.26
26.81%
08:41
08:41
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€939.20
24.09.24
24.09.24
€1,165.3
24.09.25
24.09.25
-47.87%
25.09.25
25.09.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€858.00
05.02.24
05.02.24
€1,006.8
05.02.25
05.02.25
-19.14%
06.02.25
06.02.25